Sign inJoin waitlistJoin the waitlist

Benjamin Kann

Assistant Professor of Radiation Oncology, Harvard Medical School · Mass General Brigham

Credentials: · · · · ·

History

Mass General Brigham
Present
University of Texas Southwestern Medical Center
Present

Clinical Informatics
Yale-New Haven Hospital
2024–2026
Yale-New Haven Cancer Center
2019–2024
Psychiatry
University of Texas Southwestern Medical Center
2015–2019
Radiation Oncology
Yale-New Haven Hospital
2015–2019
Transitional Year
Newton-Wellesley Hospital
2014–2015
Icahn School of Medicine at Mount Sinai
2010–2014

Research

Artificial intelligence in radiation oncology
Review · Nature Reviews Clinical Oncology · 2020 · 289 citations
Artificial intelligence for clinical oncology
Review · Cancer Cell · 2021 · First of 3 authors · 257 citations
Large language models to identify social determinants of health in electronic health records
npj Digital Medicine · 2024 · 204 citations

Raymond Mak
35 papers
Sabine Mueller
20 papers
Danielle Bitterman
17 papers · 17 as a resident
Ali Nabavizadeh
16 papers
Henry Park
14 papers · 5 as a resident
Daphne Haas-Kogan
13 papers
David Kozono
13 papers
James Yu
13 papers
Kevin Liu
13 papers · 9 as a resident
Clifton Fuller
12 papers
Barbara Burtness
11 papers
SP
Sanjay Prabhu
11 papers

Grants

CLinical ChARacterIzation of Treatment-Related MorbiditY in Pediatric Brain Tumor Survivors with Artificial Intelligence (CLARITY-AI)
National Cancer Institute · R01
Contact PI · $815.8K · Brigham and Women's Hospital
2026–2031
Harvard MD Anderson Collaborative to Reduce LyMphatic MOrbidity in Head and Neck Cancer with Artificial Intelligence (HARMONiC-AI)
National Institute of Dental and Craniofacial Research · R01
PI · $1.4M · University of Tx Md Anderson Can Ctr
2025–2030
Targeted Therapies for Glioma
National Cancer Institute · P50
Project lead · $1.4M · Brigham and Women's Hospital
2013–2029
Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science
National Cancer Institute · U54
Project lead · $128K · Dana-Farber Cancer Inst
2023–2028